US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 1.3800
  • 0.00000.00%
Close Dec 20 16:00 ET
  • 1.3800
  • 0.00000.00%
Post 20:01 ET
8.49MMarket Cap-0.90P/E (TTM)

Aytu BioPharma Key Stats

Aytu BioPharma Q1 2025 Earnings Date

Currency:USDNov 13, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
13.77M
16.57M
+2.81M
Beat Est.
-37.70%
-6.98%
+20.38%
EPS
-0.34
-0.15
+0.19
Beat Est.
+77.03%
+89.86%
+55.87%
Buy

Jul 31, 2024

Aytu BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 17.587M--
--2025/Q2-- / 15.554M--
Nov 13, 20242025/Q116.574M / 13.768M--
Sep 26, 20242024/Q417.976M / 18.301M--
May 15, 20242024/Q317.993M / 17.346M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 17.587M--
--2025/Q2-- / 15.554M--
Nov 13, 20242025/Q116.574M / 13.768M--
Sep 26, 20242024/Q417.976M / 18.301M--
May 15, 20242024/Q317.993M / 17.346M--

Unlock Free Earnings Estimates

Aytu BioPharma Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jul 31, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data